
WellQuest Medical & Wellness Corporation provides an integrated medical delivery site with family physician healthcare, preventive/wellness, and medical skin-care services. It operates medical center that provides physician-directed medical service for families and businesses, which offers a range of medical care for adults and children with digital diagnostic tests, including laboratory, X-ray, EKG, and others. The company also offers various immunizations for all ages; and weight loss program, nutritional counseling, allergy testing, fitness consulting, hormone therapy, and therapeutic massage services, as well as designs personalized treatment plans. In addition, it manufactures and sells heart support; bone and joint support; stress, mood, and sleep support; immune support; and vitamins and minerals capsules. Further, the company provides aesthetic services, which include medical spa, laser skin renewal, botox and dermal fillers, skin print technology, facials and derma sweep, Glo minerals, and teeth whitening services. Additionally, it offers corporate wellness, occupational and executive health, genetic testing, and tobacco cessation services. The company was formerly known as HQHealthQuest Medical & Wellness Centers, Ltd. and changed its name to WellQuest Medical & Wellness Corporation in April 2008. WellQuest Medical & Wellness Corporation was incorporated in 2004 and is based in Bentonville, Arkansas.
WellQuest Medical & Wellness Corporation trades as WEQL on OTC. The company is classified in Healthcare / Medical - Care Facilities and reports in USD.
The current profile places the business in Medical - Care Facilities. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Latest available fiscal data shows $5.36M of revenue and -$436,129 of net income.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
WellQuest Medical & Wellness Corporation can be compared against peers such as New York Health Care, Inc., Ventura Cannabis & Wellness Corporation, Deltagen Inc., FluoroPharma Medical, Inc., Caliber Imaging & Diagnostics, Inc., Net Medical Xpress Solutions, Inc..
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $7,212, beta of 0.48, and return on equity of +18.8%.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
WEQL currently shows total debt of $3.91M and beta of 0.48. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.wellquestmedical.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.